Noticias de LGVN_US

Noticias del mercado

Últimas noticias sobre LGVN_US — 213 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: LGVN_US ✕ 213 resultados
17/06/2026 LGVN_US — TradingKey
Longeveron Inc (LGVN) Shareholder Structure: Major Shareholders & Institutional Holdings
17/06/2026 LGVN_US — TradingKey
Longeveron Inc (LGVN) Valuation: PE, PB & Fair Value Analysis
09/06/2026 LGVN_US — Investing.com ES ← EN
Longeveron recibe el estatus de PYME del regulador europeo Por Investing.com

Longeveron receives SME status from European regulator By Investing.com

09/06/2026 LGVN_US — Investing.com Australia
Longeveron receives SME status from European regulator By Investing.com
09/06/2026 LGVN_US — The Manila Times
Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)
09/06/2026 LGVN_US — Investing.com ES ← EN
Longeveron recibe el estatus de PYME del regulador europeo Por Investing.com

Longeveron receives SME status from European regulator By Investing.com

09/06/2026 LGVN_US — Investing.com UK
Longeveron receives SME status from European regulator By Investing.com
09/06/2026 LGVN_US — Quiver Quantitative
Longeveron Inc. Awarded SME Status by European Medicines Agency, Enhancing Drug Development Opportunities

Longeveron Inc. recibe el estatus de PYME de la EMA, lo que mejora el apoyo a sus terapias celulares dirigidas a enfermedades poco comunes

09/06/2026 LGVN_US — Stock Titan
Biotech Longeveron wins EMA SME status, where SME drugs saw 89% OKs
09/06/2026 LGVN_US — Quiver Quantitative
Longeveron Inc. Awarded SME Status by European Medicines Agency, Enhancing Drug Development Opportunities

Longeveron Inc. recibe el estatus de PYME de la EMA, lo que mejora el apoyo a sus terapias celulares dirigidas a enfermedades poco comunes

09/06/2026 LGVN_US — Investing.com
Longeveron receives SME status from European regulator
07/06/2026 LGVN_US — TradingView ES ← EN
Número de accionistas de Longeveron Inc. – BARCOS:LGVN

Número de accionistas, estadísticas trimestrales y anuales de Longeveron Inc..

05/06/2026 LGVN_US — newsline.com
LGVN Q1 2026 Earnings: Deeper Losses Weigh on Shares as Clinical Progress Continues - Gross Profit Margin
05/06/2026 LGVN_US — newsline.com ES ← EN
Resultados del primer trimestre de 2026 de LGVN: pérdidas más profundas pesan sobre las acciones a medida que continúa el progreso clínico - Resultados trimestrales

LGVN Q1 2026 Earnings: Deeper Losses Weigh on Shares as Clinical Progress Continues - Quarterly Earnings

05/06/2026 LGVN_US — Stock Titan
Longeveron (NASDAQ: LGVN) CFO Lisa Locklear to step down, controller eyed as successor
05/06/2026 LGVN_US — TipRanks
Longeveron Announces CFO Transition to Internal Successor
04/06/2026 LGVN_US — BioSpace ES ← EN
Longeveron se presentará en la Convención Internacional BIO 2026

Longeveron to Present at BIO International Convention 2026

04/06/2026 LGVN_US — Stock Titan
Stem cell firm Longeveron seeks Alzheimer’s, heart partners at BIO 2026
04/06/2026 LGVN_US — Taiwan News
Longeveron to Present at BIO International Convention 2026
04/06/2026 LGVN_US — GlobeNewswire
Longeveron to Present at BIO International Convention 2026

Página 2 de 11

keyboard_arrow_up